- Home
- MVST vs AMLX Comparison
MVST vs AMLX Comparison
Compare MVST & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVST
- AMLX
- Stock Information
- Founded
- MVST 2006
- AMLX 2014
- Country
- MVST United States
- AMLX United States
- Employees
- MVST N/A
- AMLX N/A
- Industry
- MVST Industrial Machinery/Components
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- MVST Miscellaneous
- AMLX Health Care
- Exchange
- MVST Nasdaq
- AMLX Nasdaq
- Market Cap
- MVST 848.0M
- AMLX 749.9M
- IPO Year
- MVST N/A
- AMLX 2022
- Fundamental
- Price
- MVST $5.82
- AMLX $14.90
- Analyst Decision
- MVST Strong Buy
- AMLX Strong Buy
- Analyst Count
- MVST 1
- AMLX 7
- Target Price
- MVST $6.00
- AMLX $16.86
- AVG Volume (30 Days)
- MVST 11.5M
- AMLX 1.9M
- Earning Date
- MVST 11-11-2025
- AMLX 11-06-2025
- Dividend Yield
- MVST N/A
- AMLX N/A
- EPS Growth
- MVST N/A
- AMLX N/A
- EPS
- MVST N/A
- AMLX N/A
- Revenue
- MVST $422,605,000.00
- AMLX N/A
- Revenue This Year
- MVST $24.21
- AMLX N/A
- Revenue Next Year
- MVST $31.67
- AMLX N/A
- P/E Ratio
- MVST N/A
- AMLX N/A
- Revenue Growth
- MVST 20.84
- AMLX N/A
- 52 Week Low
- MVST $0.15
- AMLX $2.60
- 52 Week High
- MVST $7.12
- AMLX $15.94
- Technical
- Relative Strength Index (RSI)
- MVST 71.53
- AMLX 62.33
- Support Level
- MVST $4.38
- AMLX $13.60
- Resistance Level
- MVST $7.12
- AMLX $15.15
- Average True Range (ATR)
- MVST 0.55
- AMLX 1.05
- MACD
- MVST 0.16
- AMLX -0.03
- Stochastic Oscillator
- MVST 64.02
- AMLX 71.09
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.